Week 173 Review - Best ever week!

At last, after a pretty miserable run when everything seemed to be going wrong, along comes the biggest ever rise in portfolio value. The recovery in OPTI:Optibiotix has been rapid and huge, with this being the main driver of the improvement as the rest of the portfolio struggles. The value increased by £20,620 and zoomed back into profit, with value exceeding cost by £6,292 and total portfolio value up to £101,604. I would be celebrating getting back above £100K, but am conscious that I've recently injected £8,000 into my SIPP so I should be aiming for £108K, but it still feels great.

Thanks to my holiday I have a period of 4 weeks where I didn't follow changes in shares. The big movers therefore reflect the whole of November and I'll only mention changes above 10%.

IQE:IQE had a nightmare 4 weeks, dropping 18% on news that there will be a material effect on profits from fewer VSELs being ordered. Thank goodness I sold most of my shares when I did, as this has been slaughtered. I still believe we're in for a big bounce upwards when the shorts close, but it's difficult to see when that will be now. I'm tempted to buy in at these prices as it will significantly lower my average price per share.

CAML:Central Asia Metals is still suffering from the American trade dispute with China I think. I'm hoping for a recovery next week now that seems to be mellowing. My recent purchase actually increased my average price quite a bit so that didn't help performance, and there was a 16% drop.

TEK:Tekcapital has been a disaster in my trading account, and will teach me not to take any notice of bulletin board tips! Another big drop of 11% sees this 66% down on my purchase price.

LLOY:Lloyds Bank is one of my new shares in the SIPP having decided that the time is right to buy prior to the removal of accounting for PPI mis-selling. When this hits next October there should be a massive increase in profits and therefore dividend payouts. Unfortunately Brexit is putting on the frighteners and there was a 10% drop over the last 4 weeks. I probably ought to get some more in that case.

RED:RedT Energy also fell 10% and has now lost all the benefits that came from their big contract announcement. Only proven revenues will get this back into profit now, and it has a 47% drop to recover from since I bought them.

Although MAIS:Maistro only fell 9% I'll still give it a mention. The drop was due to a placing and announcement of an open offer at 1p a share. Given I only own 400, and given my purchase price was 24p, I decided to apply for 4,000 in the open offer costing £40. I only have to make up £109 to be able to sell these for a profit - and believe me, I will sell them as soon as I can - so all it takes is an irrational spike after the open offer and I could bail out. If not, I've just flushed £40 down the toilet!

Lots of bad news for the best ever week! Here's the good news.

SAE:Simec Atlantis Energy are finally starting to pick up as a few positive announcements have been made about potential projects and financing of the Uskmouth power station conversion. They climbed 11% but are still 69% down on my purchase price.

WRES:W Resources are getting closer to starting production and that's showing in the share price, with a climb of 12% meaning these are only 32% down now. I will be selling these as soon as in profit as I don't trust the CEO one little bit. There are so many shares in issue it's never going to pay a decent dividend even if they do make a profit.

N4P:N4 Pharma went up 18% after an announcement that the Nuvec vaccine delivery system is progressing well and has passed some of the tests. Everything depends on this one thing now, and I don't really want to be invested here as I bought these thinking they were diversified. The re-factoring business is now shut down and I don't know if they will ever recover from being 59% down on my purchase price.

Share of the Week by absolutely miles was OPTI:Optibiotix which climbed 19% to go 38% up altogether and with my recent purchase of another £4,000 worth of shares at 76p the current bid price of 92p has made an instant and healthy paper profit. My recent purchase means I now have 79,877 shares costing £53,416.53 at a weighted average price of 67p and making paper profit of £20,034.46. The recent purchase means that every 1p increase in share price is worth £798.77. Drat! Just a few more and I could have got it up to a nice round £800. That's the figure I'll be using in my head as I watch the price action.

Boing!

Here's the change in the ISA and share portfolios over the last 4 weeks

			Weekly Change
Cash	£33.80		+£7.81
Portfolio cost	£56,958.55		+£0
Portfolio sell value (bid price - commission)	£59,727.91	(4.9%)	+£6,515.11
Potential profits	£12,884.81		+£6,577.48
Yr 4 Dividends	£60.50		+£7.81
Yr 4 Profit from sales	£814.53		+£0
Yr 4 Average monthly cash profit	£219.22	(4.6%)	-£66.10
Total Dividends	£1,298.83		+£7.81
Total Profit from sales	£19,511.65		+£0
Average monthly cash profit	£517.22	(10.9%)	-£12.13
(Sold stocks profit + Dividends - Fees / Months)

The extra cash was from the dividends I mentioned last week and all the increased profit is OPTI:Optibiotix, with portfolio value not increasing as much due to drops elsewhere, but only affected by £60 so no massive drop. Long term performance is still over 10% but will be below target in a few weeks time.

Back into the black - lets hope we can stay there now.

The SIPP looks like this after ending year 3 and starting year 4 in week 157

		Weekly Change
Cash	£153.72		-£10.02
Portfolio cost	£35,825.45		+£7,931.69
Portfolio sell value (bid price - commission)	£40,089.62	(11.9%)	+£3,367.54
Potential profits	£8,088.55		+£3,725.06
Yr 4 Dividends	£0		+£0
Yr 4 Interest	£0		+£0
Yr 4 Profit from sales	£0		+£0
Yr 4 Average monthly cash profit	£0	(0%)	+£0
Total Dividends	£1,342.25		+£0
Total Interest	£0.03		+£0
Total Profit from sales	£10,544.92		+£0
Average monthly cash profit	£320.95	(10.8%)	-£8.04
(Sold stocks profit + Dividends - Fees / Months)

Cash reduced because of the monthly charge. Pension transfer explains the extra £7,931 cost and OPTI:Optibiotix increased profits by £3,725 but the drops elsewhere robbed around £350 of that with the portfolio value only climbing by £3,367. I've added a new performance line for interest as I had 3p a few weeks ago and intend to keep more cash in this portfolio so anticipate more interest payments in the future.

The big increase in portfolio cost has thumped my percentage performance figure, dropping from 14% to 10.8%. Rather annoying, but will ensure I focus on both achieving realised profits as well as paper profits.

Encouraging, as this is meant to be my lower risk portfolio and the natural state is to be in profit.

The trading account looks like this after week 123

			Weekly Change
Cash	£18.80		+£4.13
Portfolio cost	£2,321.29		+£0
Portfolio sell value (bid price - commission)	£1,580.70	(-31.9%)	-£212.71
Potential profits	£0		-£10.56
Year 3 Dividends	£17.33		+£4.13
Year 3 Profit	£177.06		+£0
Yr 3 Average monthly cash profit	£44.33	(22.9%)	-£10.63
Dividends	£18.48		+£4.13
Profit from sales	-£64.29		+£0
Average monthly cash profit	-£1.61	(-0.8%)	+£0.21
(Sold stocks profit + Dividends - Fees / Months)

Everything still tumbling and TAP:Taptica profits all vanished, so this account continues to be a disaster. The fact I've had shares long enough to get £18 dividends tells you everything you need to know about my trading skills.

Dreadful.

That's it - hoping some hints about Christmas surprises at OPTI:Optibiotix will come true as there's a momentum building that could be transformational. Certainly the awarding of the kite mark and medical device status for Slimbiome two days before a report announced type 2 diabetes can be reversed using a diet of meal replacement shakes could be epic.

Week 170-172 review - Catchup after hols

I haven't got time to do a full run-down of the three weeks I was away, and they were a depressing three weeks for the market so I don't want to dwell on them anyway.

After Week 170 the portfolio value had dropped by £2,833 which widened the deficit to £6,210 and left the portfolio value at £89,089. Note that this is much higher than the week before, and that's because my pension transfer of £8,000 came through and I spent it. Turns out I should have waited a few weeks!

Firth thing was to buy another £5,180 shares in OPTI:Optibiotix at what seemed like a bargain price of 76.98p, costing £3,999.51. These subsequently dropped to 66p and I was terribly vexed.

Next was to increase my best run company and buy 893 shares on CAML:Central Asia Metals at 222.38p costing £1,997.80. Sad to watch these drop back to 208p since then.

Next was to ensure I hedged some gold, and what better than CEY:Centamin, buying another 1,057 at 94.8864p costing £1,014.90.

Finally I wanted to get into LLOY:Lloyds Bank now we're nearing the end of the PPI claiming period. I bought 1,663 at 59.09p costing £999.53 but Brexit scares have hit them already.

Week 171 was much more horrible, with the combined portfolios dropping £7,113 and widening the deficit to £13,323 at a total value of £81,983

Some good news from dividends, with TND:Tandem Group paying out £7.81 and TAP:Taptica paying £4.13.

Week 172 was less horrible, but still lost £1,004, widening the deficit to £14,327 and portfolio value stands at £80,979

I've updated the charts, but we'll do a bumper look at what's up and down later when next week's changes are clear.

Week 169 Review - An upturn at last

About time there was some sort of turn around. The portfolio made up last week's losses and climbed £6,131 to close the deficit between cost and value to £3,377 and bring the portfolio value back up to £84,000.

Worst performer was last week's Share of the Week PAF:Pan African Resources, dropping a whopping 14% despite gold still doing quite well.

KIBO:Kibo Energy plunged 5% but it could have been much worse given TANESCO have obliterated the tenders and all this bollocks about "great relations with the Tanzanian government" is being revealed as hollow lies.

Only those two big fallers this week. Everything else good news. RED:RedT Energy and SAE:Simec Atlantis Energy both rose by 5% but have a hell of a way to go to get back to profit.

IQE:IQE went up by 9% and CAML:Central Asia Metals by 10% which was great given these are some of my biggest holdings. TAP:Taptica also climbed 10% in the trading account and is back in profit.

Share of the Week is OPTI:Optibiotix, and thank goodness. The 12% climb was responsible for most of this week's claw-back of the deficit.

OK - out of time to complete this, and off to Vietnam for 3 weeks in the morning, so I'll have to finish the snapshots when I get back and do a massive catch up. Fingers crossed when I next update I'll have my £8K pension transfer and OPTI:Optibiotix will have announced something amazing.

Week 168 Review - How can it keep getting worse?

Mega quick update as I'm behind a week and this week was so depressing. Value dropped by £6,171 making deficit between cost and value £9,508 and total portfolio value £77,869.

Worst performer was TAP:Taptica in the trading account which plunged to a loss, dropping 12% for no reason.

OPTI:Optibiotix fell another 11% and is only just in profit. This had most of the negative impact and is utterly depressing.

CAML:Central Asia Metals also had a dreadful week, dropping 6% along with AMYT:Amryt Pharma

SBTX:SkinBioTherapeutics and SAE:Simec Atlantis Energy fell 5%.

Only one share did anything, and to show how bad a week it was, Share of the Week PAF:Pan African Resources only climbed 4%.

Horrid

Here's the ISA and share account performances

			Weekly Change
Cash	£25.99		+£0
Portfolio cost	£56,958.55		+£0
Portfolio sell value (bid price - commission)	£49,558.31	(-13%)	-£4,053.78
Potential profits	£2,259.65		-£3,541.72
Yr 4 Dividends	£52.69		+£0
Yr 4 Profit from sales	£814.53		+£0
Yr 4 Average monthly cash profit	£309.10	(6.5%)	-£28.10
Total Dividends	£1,291.02		+£0
Total Profit from sales	£19,511.65		+£0
Average monthly cash profit	£532.51	(11.2%)	-£3.18
(Sold stocks profit + Dividends - Fees / Months)

Bad, bad, bad - everywhere

Yuck

Here's the SIPP after week 152

			Weekly Change
Cash	£163.74		+£133.58
Portfolio cost	£27,893.76		+£0
Portfolio sell value (bid price - commission)	£26,440.30	(-5.2%)	-£2,004.81
Potential profits	£2,282.83		-£1,860.10
Yr 3 Dividends	£426.15		+£133.58
Yr 3 Profit from sales	£1,619.73		+£0
Yr 3 Average monthly cash profit	£173.55	(7.5%)	+£8.62
Total Dividends	£1,342.25		+£133.58
Total Profit from sales	£10,544.92		+£0
Average monthly cash profit	£331.16	(14.2%)	+£1.64
(Sold stocks profit + Dividends - Fees / Months)

One fragment of good news was the £133 dividend from CAML:Central Asia Metals, taking my total dividend yield from that share to £986 which is pretty amazing. Much misery elsewhere though.

Plunges to loss for first time in ages

The trading account looks like this after week 118

			Weekly Change
Cash	£14.67		+£13.20
Portfolio cost	£2,321.29		+£0
Portfolio sell value (bid price - commission)	£1,666.12	(-28.2%)	-£112.96
Potential profits	£0		-£18.96
Year 3 Dividends	£13.20		+£13.20
Year 3 Profit	£177.06		+£0
Yr 3 Average monthly cash profit	£54.80	(30.4%)	-£4.22
Dividends	£14.35		+£13.20
Profit from sales	-£64.29		+£0
Average monthly cash profit	-£2.32	(-0.9%)	+£0.02
(Sold stocks profit + Dividends - Fees / Months)

Big drop and no potential profit.

Desperate

hat's it - not writing any more as I need to catch up this week, and it's more fun.

Week 167 Review - The decline continues

Generally it wasn't a bad week, at least compared to the last few. It was certainly a lot less volatile, but the 2p drop for OPTI:Optibiotix was enough to undo small gains elsewhere and result in a drop of £998. That widens the deficit between cost and value to £3,337 and reduces the overall portfolio value to £83,893.

I was hoping it would have increased by the £8,000 I'm transferring out of my work pension, but Legal & General have excelled themselves with their incompetence. The transfer was supposed to happen within 10 days, but rather than get it out of the way before force selling my funds as I had planned, they have decided to go ahead with that sale and re-investment even though I never wanted it. Bloody useless. As a result they are delaying the transfer until 30th October, by which time all the current bargain shares will probably have recovered. Based on this performance I'll be transferring cash out of that pension as frequently as possible, just using it as a way of getting the employer contributions. I have absolutely no confidence in them not to cock things up even more than the £600 they've already cost me.

Worst performer this week (other than Legal & General) was KIBO:Kibo Energy which is on very shaky ground now. The fact that their "great working relationship" with the authorities has metamorphosed into a request to submit tenders suggests that it's not such a cosy relationship after all. Endless delays had been tolerable because of the potential benefits, but now it's looking like the delays are just stalling and nothing is ever going to happen. I'm preparing myself for the worst now, and may have to wave goodbye to £2,000 which will have a heavy impact on my performance figures. These dropped 6% this week and are 66% down on my purchase price.

That was the only big drop this week, at least percentage wise as OPTI:Optibiotix only fell 3% but it cost me £1,500.

CAML:Central Asia Metals may have started a gradual climb, up 5% this week and one of the target shares for when my pension transfer arrives.

IQE:IQE were also up 5%, and I'm tempted to get some at sub 90p as those shorts have got to close some time, and 5g is getting nearer. The announcement that they are producing from the new reactors could see a bit of a re-rate.

SBTX:SkinBioTherapeutics usually follows OPTI:Optibiotix, but climbed 7% this week probably in anticipation of imminent news on the human trials.

Share of the Week was PAF:Pan African Resources which climbed 8% and is now 16% in profit. I have high hopes that this can double quite quickly when the announcement is made that the new project is producing. It's always been a well run company, but with a few recent issues and suspension of the dividend has been hit hard. They seem to be through that now, and given the generosity of the dividend in the past, I'm confident there will be a good re-rate.

I guess a shallower decline is an improvement!

Here's the performance of the ISA and share accounts

			Weekly Change
Cash	£25.99		+£0
Portfolio cost	£56,958.55		+£0
Portfolio sell value (bid price - commission)	£53,612.09	(-5.9%)	-£991.28
Potential profits	£5,801.37		-£1,011.92
Yr 4 Dividends	£52.69		+£0
Yr 4 Profit from sales	£814.53		+£0
Yr 4 Average monthly cash profit	£337.20	(7.1%)	-£33.72
Total Dividends	£1,291.02		+£0
Total Profit from sales	£19,511.65		+£0
Average monthly cash profit	£535.69	(11.3%)	-£3.23
(Sold stocks profit + Dividends - Fees / Months)

Profits down due to OPTI:Optibiotix, but a few quid in improving losses means the overall vaue dropped a little less. Not much else to talk about.

Same shape as the combined chart.

The SIPP looks like this after week 151

			Weekly Change
Cash	£30.16		+£0
Portfolio cost	£27,893.76		+£0
Portfolio sell value (bid price - commission)	£28,445.11	(2%)	-£67.29
Potential profits	£4,142.93		-£157.60
Yr 3 Dividends	£292.57		+£0
Yr 3 Profit from sales	£1,619.73		+£0
Yr 3 Average monthly cash profit	£164.93	(7.1%)	-£3.58
Total Dividends	£1,208.67		+£0
Total Profit from sales	£10,544.92		+£0
Average monthly cash profit	£329.52	(14.2%)	-£2.19
(Sold stocks profit + Dividends - Fees / Months)

The increase in potential profits for PAF:Pan African Resources and CAML:Central Asia Metals was almost enough to nullify the losses from OPTI:Optibiotix, but not quite. I think we can regard this as a flat week compared to recent ones.

That's such a narrow gap!

The trading account looks like this after week 117

			Weekly Change
Cash	£1.47		-£150.00
Portfolio cost	£2,321.29		+£0
Portfolio sell value (bid price - commission)	£1,779.08	(-23.4%)	+£60.40
Potential profits	£18.96		-£8.40
Year 3 Dividends	£0		+£0
Year 3 Profit	£177.06		+£0
Yr 3 Average monthly cash profit	£59.02	(30.5%)	-£4.92
Dividends	£1.15		+£0
Profit from sales	-£64.29		+£0
Average monthly cash profit	-£2.34	(-1.2%)	+£0.02
(Sold stocks profit + Dividends - Fees / Months)

Coo - an account that actually increased in value! It seems like a long time since I was able to write that.

Cash reduced as I banked £150 profit after deciding I need the money. For now I won't grow the size of this account but keep the ability to have 5 shares on the go. Given the value is way below the £2,500 needed, that could be easier said than done!

Most of the gains were thanks to CAML:Central Asia Metals and IQE:IQE, but TAP:Taptica dropped in value again so potential profits are down and it's looking like I won't be selling anything in a hurry. They are quite volatile though, so could climb quickly. LION:Lionsgold issued an RNS suggesting I shouldn't hold my breath for their suspension being lifted.

Although the value increased, the removal of £150 means the green line takes a dive, but the orange line also drops as I try to take out the capital I started the account with. Once that gets to £0 I'll keep the cash in the account and allow it to grow. "If" might be the word rather than "When"!

I now know there will be no pension money next week, so not much to look forward to. I'd hoped to buy more OPTI:Optibiotix while the price was low, but can tolerate keeping my existing holding and investing in something else instead. CEY:Centamin and CAML:Central Asia Metals are the two main candidates at the moment, with maybe a small top-up of IQE:IQE.

Week 166 Review - Carnage as portfolio crashes into the red

The best thing I can say about this week is that it wasn't as bad as last week. However, it was nearly as bad, with the combined portfolios losing £8,004 in value and going into a paper loss. The deficit between cost and value is £2,339 and total portfolio value has dropped to £85,042. It was £117K just 9 weeks ago. £32K vanished in 2 months. That makes me sad!

The list of major fallers is huge so I won't go into detail, as there's no reason for the drops other than a general crash of the AIM market.

CAML:Central Asia Metals was the worst performer, dropping 16% and as one of my biggest holdings it had a big impact. TAP:Taptica had a much smaller impact dropping 14% is it's a small holding in my trading account, but I'm kicking myself that I didn't take the £100 profit when I had a chance as I could have bought them back now.

OPTI:Optibiotix released more amazing news this week, including the wife of a director buying 125,000 shares, but whenever good news is announced it's a disaster for the share price, and true to form it lost another 12% and was responsible for most of this week's decline.

SBTX:SkinBioTherapeutics was also a double-digit loser, falling 10%, RED:RedT Energy and MTFB:Motif Bio dropped 9%, with MTFB:Motif Bio going into loss. TEK:Tekcapital dropped 8%, AMYT:Amryt Pharma dropped 7%, MMX:Minds + Machines and KIBO:Kibo Energy dropped 6%, and JLP:Jubilee Metals dropped 5%.

Only two shares went up this week. PAF:Pan African Resources was a negligible gain, and Share of the Week was CEY:Centamin which climbed 7% as the gold price rallied.

So - patronising Legal & General pensions "expert" that pointed out my gold fund is in mining stocks and so was just as susceptible to stock market crashes as other funds can go jump off a cliff. Good news is that the debacle with them forcing me to sell funds bought as long term investments has enabled me to see just how easy it is to transfer money out of my crappy Legal & General work pension and into my SIPP. It took 30 seconds to arrange for £8,000 to be transferred and I should get it within 10 days. Go stick that up your nether regions Legal & General! I shall now transfer out of my work pension every time it gets over £1,000 so I can keep receiving my employers contribution but don't have to trust a company that's screwed me over to look after my money. Fortunately the bulk of my pension is locked away in a final salary scheme so there are only 12 months contributions in the new one, so happy to put up with a bit of risk on that pot.

Looks like Mount Everest - and I just fell off!

Here's the performance of the ISA and share accounts

			Weekly Change
Cash	£25.99		+£0
Portfolio cost	£56,958.55		+£0
Portfolio sell value (bid price - commission)	£54,603.37	(-4.1%)	-£5,172.09
Potential profits	£6,813.29		-£4,116.32
Yr 4 Dividends	£52.69		+£0
Yr 4 Profit from sales	£814.53		+£0
Yr 4 Average monthly cash profit	£370.92	(7.8%)	-£41.21
Total Dividends	£1,291.02		+£0
Total Profit from sales	£19,511.65		+£0
Average monthly cash profit	£538.92	(11.4%)	-£3.27
(Sold stocks profit + Dividends - Fees / Months)

Take the OPTI:Optibiotix paper profits crash out of the equation and losses deepened by a further £1,000. Nothing more to say.

Looking at the longer term trend, the current value seems about in line - lets hope that means it won't drop any further.

Here's the SIPP after week 150

			Weekly Change
Cash	£30.16		+£0
Portfolio cost	£27,893.76		+£0
Portfolio sell value (bid price - commission)	£28,512.40	(2.2%)	-£2,667.04
Potential profits	£4,300.53		-£2,499.10
Yr 3 Dividends	£292.57		+£0
Yr 3 Profit from sales	£1,619.73		+£0
Yr 3 Average monthly cash profit	£168.51	(7.2%)	-£3.75
Total Dividends	£1,208.67		+£0
Total Profit from sales	£10,544.92		+£0
Average monthly cash profit	£331.71	(14.3%)	-£2.23
(Sold stocks profit + Dividends - Fees / Months)

Nearly all the losses were reduced paper profit for CAML:Central Asia Metals and OPTI:Optibiotix, with another few hundred quid of deepening loss elsewhere.

At least this account stayed in the black!

Here's the trading portfolio after week 116

			Weekly Change
Cash	£151.47		+£0
Portfolio cost	£2,321.29		+£0
Portfolio sell value (bid price - commission)	£1,718.68	(-26%)	-£165.71
Potential profits	£27.36		-£67.20
Year 3 Dividends	£0		+£0
Year 3 Profit	£177.06		+£0
Yr 3 Average monthly cash profit	£66.94	(33.1%)	-£5.81
Dividends	£1.15		+£0
Profit from sales	-£64.29		+£0
Average monthly cash profit	-£2.36	(-1.2%)	+£0.02
(Sold stocks profit + Dividends - Fees / Months)

Worst ever week for this account, with most of my un-banked profits wiped out for TAP:Taptica and the rest of the portfolio losing another £100. Still no sign of LION:Lionsgold ever coming out of suspension. I think I'm going to take out the £150 cash. I need it to go towards my holiday costs - I'm happy for this account to just hover around £2,000 and use it as a piggy bank - albeit not a very productive piggy bank so far!

My new target for this account is to get the injection line down to zero.

That's it for a horrid week. It could have been much more horrid if Friday hadn't recovered slightly. With the pension funds due soon I'm hoping the recovery won't be too swift, as I want to buy CEY:Centamin, CAML:Central Asia Metals - and yes - a few more OPTI:Optibiotix while they are madly cheap.

Week 165 Review - Utter and complete misery

This week's update is late, partly because I was away for the weekend and partly because it's too depressing for me to want to write it. The combined portfolios lost £8,888 and went from over £100K to £93,046 reducing the buffer between value and cost to just £5,665 and as we're already halfway through week 166 I can say that's all gone and Friday's update promises to be as bleak as this one.

Leading the fallers is OPTI:Optibiotix, falling 17% this has dropped from 130p to 88p in a few weeks and all the profits I was strongly advised not to top-slice by the CEO have gone. I still think he was right to advise that, and I'm sure this share price is being manipulated, so I can't blame him. It was my decision to keep them, and I stand by it, as I firmly believe they will be back at 130p soon.

RED:RedT Energy dropped 16% putting an end to their brief rise.

CEY:Centamin dropped 11% as they continue to plummet against all odds. I'll soon be getting £8,000 transferred into my SIPP from my work pension, as I've discovered it's rather easy and Legal & General have screwed me over. They are force-selling my Blackrock Gold fund at a really low price and buying a general fund at a high price. I believed I was investing for the long term, but they've absolutely buggered up my long term strategy and have no gold option to re-invest the proceeds in because they feel it's "too specialised". Is it bollocks!! So I shall be transferring my monthly contributions into my SIPP and managing it myself every time there's £1,000. £4,000 of the proceeds will be going straight into CEY:Centamin at these prices.

MTFB:Motif Bio, RDT:Rosslyn Data and SBTX:SkinBioTherapeutics all dropped 5% for no reason.

Only 2 shares rose by more than 5%. IKA:Ilika climbed 6% after news of a new research partnership (still years away from delivering anything) and Share of the Week is MMX:Minds + Machines which climbed 10% but is still 13% down.

Really, really depressing

Here's the combined ISA and share portfolio

			Weekly Change
Cash	£25.99		+£19.38
Portfolio cost	£56,958.55		+£0
Portfolio sell value (bid price - commission)	£59,776.46	(4.9%)	-£6,202.55
Potential profits	£10,929.61		-£5,794.38
Yr 4 Dividends	£52.69		+£23.13
Yr 4 Profit from sales	£814.53		+£0
Yr 4 Average monthly cash profit	£412.13	(8.7%)	-£41.02
Total Dividends	£1,291.02		+£23.13
Total Profit from sales	£19,511.65		+£0
Average monthly cash profit	£542.19	(11.4%)	-£2.79
(Sold stocks profit + Dividends - Fees / Months)

There was a £23.13 dividend from CEY:Centamin but £3.75 was taken as ISA charge so cash is just up by £19. £5,795 paper profits evaporated and deepening losses reduced value by £6,202. Average profit should stay above 10% for another 14 weeks without me having to sell anything.

We seem to be in a very volatile phase.

The SIPP looks like this after week 149

			Weekly Change
Cash	£30.16		-£12.67
Portfolio cost	£27,893.76		+£0
Portfolio sell value (bid price - commission)	£31,179.44	(11.8%)	-£2,670.64
Potential profits	£6,799.63		-£2,717.83
Yr 3 Dividends	£292.57		+£0
Yr 3 Profit from sales	£1,619.73		+£0
Yr 3 Average monthly cash profit	£172.26	(7.4%)	-£5.16
Total Dividends	£1,208.67		+£0
Total Profit from sales	£10,544.92		+£0
Average monthly cash profit	£333.94	(14.4%)	-£2.63
(Sold stocks profit + Dividends - Fees / Months)

Cash dropped by £12 due to monthly charges. Paper profits dropped by more than the value dropped, so some losses were reduced as MMX: Minds + Machines improved. Nothing else happened really.

Same story as above but with a slightly wider buffer to the red line

Trading looks like this after week 115

			Weekly Change
Cash	£151.47		+£0
Portfolio cost	£2,321.29		+£0
Portfolio sell value (bid price - commission)	£1,884.39	(-18.8%)	-£15.62
Potential profits	£102.96		-£5.04
Year 3 Dividends	£0		+£0
Year 3 Profit	£177.06		+£0
Yr 3 Average monthly cash profit	£76.73	(39.7%)	-£8.52
Dividends	£1.15		+£0
Profit from sales	-£64.29		+£0
Average monthly cash profit	-£2.40	(-1.2%)	+£0.02
(Sold stocks profit + Dividends - Fees / Months)

The usual tick down in value and TAP:Taptica keeps dropping so it looks like I should have taken those profits a few weeks ago. No doubts I'll watch them dwindle away as everything else continues to get hammered.

At least the decline is slow, but relentless.

That's it - utterly fed up and it's getting worse. Not looking forward to Friday's update unless something very unlikely happens over the next 2 days.